Milligan Michael Lee sold Neumora Therapeutics ($NMRA) shares once on the open market in the last year for a total of $5,119. His most recent sale occurred on February 17, 2026. He made no open market purchases. Among 11,678 insiders, his sales rank 11,399th, well below the average of $8.6 million across 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | S | Common Stock | 1436 | $3.57 | 21,034.0000 | 167,089,114 | 6.39% | 0.00% |
| Jan. 8, 2026 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 167,089,114 | 9999.99% | 0.21% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 28675 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 41250 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.03% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 400000 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.25% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 85391 | $0.00 | 85,391.0000 | 161,978,923 | 9999.99% | 0.05% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 38234 | $0.00 | 38,234.0000 | 161,978,923 | 9999.99% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 28675 | $0.00 | 28,675.0000 | 161,978,923 | 9999.99% | 0.02% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 41250 | $0.00 | 41,250.0000 | 161,978,923 | 9999.99% | 0.03% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 161,978,923 | 9999.99% | 0.25% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 85391 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.05% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 38234 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.02% |
| Feb. 18, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | S | Common Stock | 1978 | $1.69 | 22,470.0000 | 0 | 8.09% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 38234 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 28675 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 41250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 85391 | $0.00 | 85,391.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 38234 | $0.00 | 38,234.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | D | Stock Option (Right to Buy) | 85391 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 28675 | $0.00 | 28,675.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Common Stock | 20625 | $0.00 | 24,448.0000 | 0 | 539.50% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | Milligan Michael Lee | See Remarks | A | Stock Option (Right to Buy) | 41250 | $0.00 | 41,250.0000 | 0 | 9999.99% | 0.00% |